Breaking News, Collaborations & Alliances

BioGenes and Alphalyse Partner to Improve the Future of HCP Monitoring

Aim to enable a solid HCP surveillance strategy including quantification and identification of relevant HCPs.

Author Image

By: Charlie Sternberg

Associate Editor

Recently, BioGenes and Alphalyse, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years, partnered up to offer their respective methods to biologics developers for optimal outcomes. While BioGenes specializes in the development of HCP ELISAs and related 2D gel analytics, Alphalyse is an expert in HCP coverage analysis by Liquid Chromatography (LC) – Mass Spectrometry (MS).   HCPs stem from the production cell line used for biological product...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters